Figures & data
Figure 1. Deconvoluted mass spectrum of denatured and reduced Fc-G4P-protein. The Fc is linked to the protein via a G4P linker. Typical Fc glycosylation (G0F, G1F, G2F, etc.) was observed. Modification #1 represents about 45% of the MS signal based on peak height.
![Figure 1. Deconvoluted mass spectrum of denatured and reduced Fc-G4P-protein. The Fc is linked to the protein via a G4P linker. Typical Fc glycosylation (G0F, G1F, G2F, etc.) was observed. Modification #1 represents about 45% of the MS signal based on peak height.](/cms/asset/0c6b8de0-4194-4941-be81-a47002656e58/kmab_a_1325556_f0001_c.gif)
Figure 2. A high level +15.99 Da mass increase was observed on the G4P linker peptide by LC-MS/MS. Based on peptide signal intensity, there is a ratio of about 60:40 of unmodified peptide: modified peptide. Top panel: XIC (Extracted Ion Chromatogram) of unmodified and modified peptides. Bottom panel: Centroid mass spectrum averaged from T21.5–24.5 min.
![Figure 2. A high level +15.99 Da mass increase was observed on the G4P linker peptide by LC-MS/MS. Based on peptide signal intensity, there is a ratio of about 60:40 of unmodified peptide: modified peptide. Top panel: XIC (Extracted Ion Chromatogram) of unmodified and modified peptides. Bottom panel: Centroid mass spectrum averaged from T21.5–24.5 min.](/cms/asset/197a80c6-46c0-417a-948e-ca8ba7bdf7df/kmab_a_1325556_f0002_c.gif)
Figure 3. Low-resolution CID mass spectra of unmodified and +15.99 Da modified ([M+2H]2+ = 614.82) linker peptide SLSLSPGGGGGPAR. The modification can be localized to the GGGPAR portion of the sequence by the difference in y6 ions. Different b13 ions eliminate the C-terminal R.
![Figure 3. Low-resolution CID mass spectra of unmodified and +15.99 Da modified ([M+2H]2+ = 614.82) linker peptide SLSLSPGGGGGPAR. The modification can be localized to the GGGPAR portion of the sequence by the difference in y6 ions. Different b13 ions eliminate the C-terminal R.](/cms/asset/9742d882-5a4a-4945-872c-8411846e533f/kmab_a_1325556_f0003_c.gif)
Figure 4. High-resolution HCD mass spectrum of +15.99 Da modified ([M+2H]2+ = 614.82) linker peptide SLSLSPGGGGGPAR. Top panel: m/z [100–1250]. Bottom panel: m/z [340–460]. The detected accurate masses of the y3 and y4 fragment ions rule out Pro221→ Leu/Ile221 mutation. The HCD fragmentation cannot discriminate between Pro221→Hyp221 or Ala222→Ser222 as no y2 fragment ion was observed.
![Figure 4. High-resolution HCD mass spectrum of +15.99 Da modified ([M+2H]2+ = 614.82) linker peptide SLSLSPGGGGGPAR. Top panel: m/z [100–1250]. Bottom panel: m/z [340–460]. The detected accurate masses of the y3 and y4 fragment ions rule out Pro221→ Leu/Ile221 mutation. The HCD fragmentation cannot discriminate between Pro221→Hyp221 or Ala222→Ser222 as no y2 fragment ion was observed.](/cms/asset/eea9062e-ebe8-4f1c-ac94-c37e3b969121/kmab_a_1325556_f0004_c.gif)
Figure 5. CID/HCD MS3 spectrum of m/z 741.36, i.e. y9 ion resulting from CID fragmentation of the +15.99 Da modified peptide (see Bottom Panel of ). HCD fragmentation of the 741.36 ion yields unique a7 and b7 fragment ions that confirm a Pro221→Hyp 221 post-translational modification.
![Figure 5. CID/HCD MS3 spectrum of m/z 741.36, i.e. y9 ion resulting from CID fragmentation of the +15.99 Da modified peptide (see Bottom Panel of Fig. 3). HCD fragmentation of the 741.36 ion yields unique a7 and b7 fragment ions that confirm a Pro221→Hyp 221 post-translational modification.](/cms/asset/5f94ead0-52a9-4229-a2ce-3e9dff7fd8d5/kmab_a_1325556_f0005_c.gif)